Richard Gale

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos et al. · The Lancet · 2017 · 372 citations · Full text

Diabetic Retinopathy, Ocular Disease, Retina +7

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Benchmark standards for refractive outcomes after NHS cataract surgery

Richard Gale, Manuel Saldaña, Robert L. Johnston et al. · Eye · 2007 · 264 citations · Full text

Benchmark Standards, Ophthalmic Surgery, Ophthalmology +5

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis

Andrew D. Dick, James T. Rosenbaum, Hassan Al-Dhibi et al. · Ophthalmology · 2018 · 244 citations · Full text

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Andrew Lotery, Sobha Sivaprasad, Abby O’Connell et al. · The Lancet · 2020 · 218 citations · Full text